Liminal BioSciences Announces FDA Approval for its Biologics License Application for Ryplazim® (plasminogen, human-tvmh)
/PRNewswire/ - Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company") announced today that the U.S. Food & Drug Administration (FDA)...
United Kingdom Bioscience Ryplazim Exchange Commission Prometic Bioproduction Inc Us Food Drug Administration Prometic Biotherapeutics Inc
Source: prnewswire.com